Search clinical trials for: pharmacogenomics

Total 125 results

Nalagenetics Pte Ltd

Active, not recruiting

Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)

Pre-emptive Pharmacogenomics

Singapore
Anderson Orthopaedic Research Institute

Unknown

Pharmacogenetics for Pain Management in Joint Replacement Patients (PGx)

Arthroplasty Complications

United States
Clinical and Translational Genome Research Institute...
Children's Specialized Hospital

Terminated

Pharmacogenomics for Improving Pediatric ADHD Treatment

Attention Deficit Disorders With Hyperactivity

United States
Geisinger Clinic

Enrolling by invitation

Preemptive Pharmacogenomics Testing Among Geriatric Patients

Polypharmacy | Pharmacogenomic Testing

United States
Data Collection Analysis Business Management
PAS Research Services

Unknown

Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)

Pharmacogenomic

United States
Mayo Clinic

Terminated

The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients

Palliative Medicine

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI); Peloton Therapeutics, Inc.

Completed

HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma (PT2385)

Recurrent Glioblastoma

United States
Wake Forest University Health Sciences

Terminated

LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Study of Pain Management in Oncology Outpatients

Malignant Tumor of Ill-defined Site

United States
Avera McKennan Hospital & University Health Center

Completed

Developing an Interdisciplinary Pharmacogenomic Treatment Approach to Reduce Medication Burden and Improve Outcomes

Developmental Disabilities
M.D. Anderson Cancer Center

Completed

Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma

Metastatic Carcinoma in the Adrenal Cortex | Stage III Adrenal Cortex Carcinoma AJCC v8 | Stage IV Adrenal Cortex Carcinoma AJCC v8 | Unresectable Adrenal Cortex Carcinoma

United States
Auburn University
Tuscaloosa Veterans Affairs Medical Center

Withdrawn

Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans

Depressive Disorder, Major | Pharmacogenetics | Medication Therapy Management

United States
Murdoch Childrens Research Institute

Recruiting

Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC) (MARVEL-PIC)

Neoplasms | Bone Marrow Transplantation

Australia
Mayo Clinic

Completed

Utility of Pharmacogenomic Testing in Patients With Gastrointestinal Disorders

Gastrointestinal Diseases

United States
Tabula Rasa HealthCare

Withdrawn

Implementation of a Pharmacist-led Pharmacogenomic Clinical Service

Elderly | Adverse Drug Event | Pharmacogenomics | Drug Drug Interaction

United States
Tabula Rasa HealthCare

Enrolling by invitation

Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting

Polypharmacy | Pharmacogenomics

United States
Mayo Clinic

Completed

Right Drug, Right Dose, Right Time - Using Genomic Data to Individualize Treatment

Healthy Subjects
Wake Forest University Health Sciences

Completed

Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation (IMPPACT)

Oncology | Hematopoietic Cell Transplantation

United States
Wake Forest University Health Sciences

Completed

Pharmacogenomic Testing to Personalize Supportive Oncology

Depression | Pain | Cancer

United States
National Cancer Institute (NCI)

Active, not recruiting

Vismodegib in Treating Patients With Advanced Chondrosarcomas

Mesenchymal Chondrosarcoma | Dedifferentiated Chondrosarcoma | Unresectable Primary Central Chondrosarcoma | Clear Cell Chondrosarcoma | Locally Advanced Chondrosarcoma | Metastatic Chondrosarcoma | Primary Central Chondrosarcoma

France
University of North Carolina, Chapel Hill
Laboratory Corporation of America; Kerr Drug

Completed

Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy

Myocardial Infarction | Stroke | Transient Ischemic Attack

United States
Lawson Health Research Institute

Not yet recruiting

Personalized Pharmacotherapy Using Pharmacogenetics in Veterans (PGx)

Pharmacogenetic Testing to Determine Pharmacological Treatment in PTSD
University Hospital, Montpellier

Completed

Study of Tissue Samples From Patients With Glioma or Other Brain Tumors

Central Nervous System Lymphoma

France
Azienda Socio Sanitaria Territoriale degli Spedali...
IRCCS Istituto Centro San Giovanni di Dio- Fatebenefratelli

Recruiting

Clinical Validation of a Combinatorial Pharmacogenomic Approach in Major Depressive Disorder (PANDORA)

Major Depressive Disorder

Italy
Avera McKennan Hospital & University Health Center
Avera Heart Hospital of South Dakota; North Central Heart Institute

Completed

Pharmacogenomics and Effective Treatment With Clopidogrel

Pharmacogenomics and Cardiovascular Events

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma

Lymphoma
University of Chicago
National Cancer Institute (NCI)

Terminated

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer

Clear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer

United States
National Cancer Institute (NCI)

Terminated

Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia

Recurrent Small Lymphocytic Lymphoma | B-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia

United States
University of Michigan

Completed

Pharmacogenomic Testing in Primary Care

Antidepressants Causing Adverse Effects in Therapeutic Use

United States
Columbia University

Terminated

Pharmacogenomic Testing in Major Depressive Disorder

Major Depressive Disorder

United States
J.J.Swen
Karolinska Institutet; Medical University of Vienna; Uppsala University; St. Antonius... and other collaborators

Completed

PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions (PREPARE)

Adverse Drug Reaction

Austria, Netherlands, Italy, Greece, Slovenia, Spain, United Kingdom
Second Affiliated Hospital, School of Medicine,...

Completed

A Single-center Randomized Controlled Study on the Effect of Pharmacogenomics Trial on Clinical Efficacy in Patients With Depression

Depressive Disorder | Pharmacogenomic Drug Interaction

China
Mayo Clinic
Assurex Health Home

Completed

Evaluation of an Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting

Depression

United States
National University of Singapore
Collabring Pte Ltd

Not yet recruiting

Personalised Hyperlipidaemia Therapies Guided by Pharmacogenomics (LipidPgx)

Cardiovascular Diseases
University of Chicago

Recruiting

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

Breast Cancer | Head and Neck Cancer | Gastrointestinal Cancer | Dihydropyrimidine Dehydrogenase Deficiency | UGT1A1 Gene Mutation

United States
Kaiser Permanente
OneOme, LLC

Active, not recruiting

Effectiveness of PGx Testing

Polypharmacy

United States
AB Biotics, SA
Hospital Clinic of Barcelona

Completed

Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression

Bipolar Disorder

Spain
University of Alabama at Birmingham

Completed

Genetic Evaluation for Medication Selection (GEMS) Study (GEMS)

Dementia | Behavior Disorders | Psychiatric Disorders Mood

United States
Assistance Publique Hopitaux De Marseille

Not yet recruiting

PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia (PROMISE)

Patients With Schizophrenia
Takeda

Completed

Case Control Study of Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate

Toxicity

United States, Argentina, Poland, South Africa, Russian Federation, Netherlands, Chile, Canada, Germany, Latvia, Finland, United Kingdom, Czech Republic, Slovakia
National Cancer Institute (NCI)

Completed

AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer

United States
National Cancer Institute (NCI)
Glaxosmithkline Biologicals S.A.

Terminated

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Renal Failure | Solid Neoplasm | BRAF Gene Mutation | Hepatic Complication

United States, Canada
Mayo Clinic

Completed

Genomic Opioid Optimization of Dosing and Selections (GOODS) Study

Perioperative/Postoperative Complications

United States
European Organisation for Research and Treatment...

Terminated

Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy

Lung Cancer

Netherlands, Belgium, United Kingdom, Egypt, France, Germany, Slovenia, Greece
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Breast Cancer
National Cancer Institute (NCI)

Withdrawn

Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Unresectable Extrahepatic Bile Duct Cancer | Stage II Gallbladder Cancer | Stage IIIA Gallbladder Cancer | Stage IIIB Gallbladder... and other conditions
Amir Mortazavi
National Cancer Institute (NCI); Arno Therapeutics

Completed

AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma

Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse... and other conditions

United States
John Papastergiou Pharmacy Ltd
Green Shield Canada

Completed

Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy

Depression | Mood Disorders | Generalized Anxiety Disorder | Anxiety | Major Depressive Disorder

Canada
University of Arizona
OneOme, LLC

Not yet recruiting

CDDOM Oneome Rightmed Depression Study

Depression, Anxiety
National Cancer Institute (NCI)

Terminated

Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive

United States
National Cancer Institute (NCI)

Terminated

RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma

United States

Search clinical trials for: pharmacogenomics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations